HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 22 filers reported holding HEMISPHERX BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $26,000 | +188.9% | 163,131 | +217.7% | 0.00% | – |
| Q4 2018 | $9,000 | +28.6% | 51,343 | +54.8% | 0.00% | – |
| Q3 2018 | $7,000 | 0.0% | 33,169 | +60.6% | 0.00% | – |
| Q2 2018 | $7,000 | +600.0% | 20,658 | +1105.3% | 0.00% | – |
| Q1 2018 | $1,000 | -66.7% | 1,714 | -71.9% | 0.00% | – |
| Q4 2017 | $3,000 | +200.0% | 6,102 | +282.8% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 1,594 | -38.2% | 0.00% | – |
| Q2 2017 | $1,000 | -80.0% | 2,581 | -73.3% | 0.00% | – |
| Q1 2017 | $5,000 | -28.6% | 9,675 | -5.1% | 0.00% | – |
| Q4 2016 | $7,000 | +75.0% | 10,200 | +192.8% | 0.00% | – |
| Q3 2016 | $4,000 | – | 3,484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Occidental Asset Management, LLC | 15,834 | $6,000 | 0.00% |
| Virtu Financial LLC | 34,330 | $14,000 | 0.00% |
| Waldron Private Wealth LLC | 11,000 | $4,000 | 0.00% |
| VANGUARD GROUP INC | 451,169 | $178,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,080 | $0 | 0.00% |
| UBS Group AG | 1,714 | $1,000 | 0.00% |
| Well Done, LLC | 190 | $0 | 0.00% |
| Advisor Group, Inc. | 250 | $0 | 0.00% |
| Jacobi Capital Management LLC | 318 | $0 | 0.00% |
| CITY HOLDING CO | 417 | $0 | 0.00% |